Institute of Clinical Physiology, National Research Council, Pisa, Italy.
Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):523-8. doi: 10.1097/MCO.0b013e328358be7b.
To evaluate the relationship between cardiac fat accumulation and insulin resistance. We discuss the current knowledge regarding the different techniques for measuring, in vivo in humans, cardiac fat deposition, the effects of systemic and myocardial insulin resistance and the clinical relevance of the relation between atherosclerosis and cardiac fat in conditions of insulin resistance.
In humans, fat accumulates mainly around the heart, as epicardial, perivascular and intrathoracic fat, but also inside the cardiomyocytes. All these cardiac fat depots have been shown to be markers of cardiac lipotoxicity, mitochondrial dysfunction, inflammation and local and systemic insulin resistance as well as of atherosclerosis and cardiac dysfunction.
Although cardiac fat is associated with impairment in heart metabolism and cardiac dysfunction, the interplay among cardiac fat accumulation, insulin resistance and cardiac dysfunction remains to be fully established.
评估心脏脂肪堆积与胰岛素抵抗之间的关系。我们讨论了目前关于在人体中测量心脏脂肪沉积的不同技术、系统性和心肌胰岛素抵抗的影响以及胰岛素抵抗状态下动脉粥样硬化与心脏脂肪之间关系的临床相关性。
在人体中,脂肪主要积聚在心脏周围,包括心外膜脂肪、血管周围脂肪和胸腔内脂肪,但也存在于心肌细胞内。所有这些心脏脂肪沉积都被证明是心脏脂肪毒性、线粒体功能障碍、炎症以及局部和系统性胰岛素抵抗以及动脉粥样硬化和心脏功能障碍的标志物。
尽管心脏脂肪与心脏代谢受损和心脏功能障碍有关,但心脏脂肪堆积、胰岛素抵抗和心脏功能障碍之间的相互作用仍有待充分确定。